PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16112956-6 2005 Patients with signs of exercise-induced ischemia by dobutamine stress echocardiography have been reported to have higher baseline BNP values. Dobutamine 52-62 natriuretic peptide B Homo sapiens 130-133 21297144-6 2011 The receiver-operating characteristic curve demonstrated BNP levels >190 pg/ml as predictor of ICU >5 days and BNP levels >20.5 pg/ml correlated with dobutamine use, with areas under the curve of 0.712 and 0.842, respectively. Dobutamine 159-169 natriuretic peptide B Homo sapiens 117-120 20729741-8 2010 Dobutamine induced a marked improvement in myocardial performance associated to a decrease in BNP levels. Dobutamine 0-10 natriuretic peptide B Homo sapiens 94-97 19401301-9 2009 A correlation was found between increase in IVA under Dobutamine and BNP levels (r = 0.57, P < 0.02). Dobutamine 54-64 natriuretic peptide B Homo sapiens 69-72 19401301-10 2009 CONCLUSION: Elevated BNP levels correlate with response of systolic right ventricular function assessed by IVA to Dobutamine stress. Dobutamine 114-124 natriuretic peptide B Homo sapiens 21-24 16849043-1 2007 AIMS: Aim of the study was to determine the effect of dobutamine stress echocardiography (DSE)-induced ischemia on circulating levels of N-terminal fragment of B-type natriuretic peptide (NT-pro-BNP). Dobutamine 54-64 natriuretic peptide B Homo sapiens 195-198 17218198-2 2007 Data regarding BNP as a marker of ischemia during dobutamine stress echocardiography (DSE) are not conclusive. Dobutamine 50-60 natriuretic peptide B Homo sapiens 15-18 16015444-5 2005 At dobutamine echocardiography, a composite of dysfunctional and ischemic myocardium was the strongest correlate of BNP (r = 0.48, p < 0.0001), with less strong correlations by global parameters. Dobutamine 3-13 natriuretic peptide B Homo sapiens 116-119 22471594-10 2012 Dobu, Epi, Nor, and LPS significantly increased BNP concentration but not TNF-alpha, IL-1beta, or IL-6. Dobutamine 0-4 natriuretic peptide B Homo sapiens 48-51 22471594-11 2012 CONCLUSIONS: In vitro, LPS, Dobu, Epi, and Nor induced BNP synthesis by human atrial myocardium. Dobutamine 28-32 natriuretic peptide B Homo sapiens 55-58 21297144-5 2011 RESULTS: Preoperative BNP levels correlate with longer ICU stay (P = 0.003), longer ventilator use (P = 0.018) and duration of dobutamine use (P < 0.001). Dobutamine 127-137 natriuretic peptide B Homo sapiens 22-25 19539144-0 2009 Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Dobutamine 66-76 natriuretic peptide B Homo sapiens 8-34 15019872-0 2004 Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Dobutamine 68-78 natriuretic peptide B Homo sapiens 21-46 15019872-7 2004 The change in BNP levels with dobutamine stress was not associated with ischemia. Dobutamine 30-40 natriuretic peptide B Homo sapiens 14-17 15019872-9 2004 In this pilot study, resting BNP was predictive of dobutamine-induced ischemia. Dobutamine 51-61 natriuretic peptide B Homo sapiens 29-32 10441688-5 1999 The ANP, BNP, and cGMP concentrations decreased in 11 of the 14 patients during dobutamine infusion. Dobutamine 80-90 natriuretic peptide B Homo sapiens 9-12 10441688-12 1999 In conclusion, rapid changes in ANP, BNP, and cGMP concentrations during dobutamine infusion reflect the changes in atrial and ventricle pressure and volume overload. Dobutamine 73-83 natriuretic peptide B Homo sapiens 37-40 28220640-5 2017 The dobutamine-induced changes of all speckle tracking indices predicted cardiac mortality, while, among resting echocardiographic parameters, only RS and RSR predicted survival, after adjusting for age, sex, cardiomyopathy aetiology, NYHA class, AF, BNP levels, resting LVED, and LV outflow tract velocity-time integral, and their respective changes produced by dobutamine (P < 0.05). Dobutamine 4-14 natriuretic peptide B Homo sapiens 251-254